Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy

Figure 4

Microperimetry of patient #4 at baseline, 1 and 3 months after IV. Detail of the 36 points tested and their evolution.